Reduced Oxycodone Efficacy Associated With Carbamazepine Use in a Patient With Advanced Cholangiocarcinoma
Cureus · 01.11.2026
DOI: 10.7759/cureus.118925 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cureus, erschienen am 01.11.2026. Verfasst von Kim M Dorward und 1 weiteren Autor:innen. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Drug-drug interactions are a frequently under-recognised cause of suboptimal symptom control in palliative care.We describe a case of a 72-year-old woman with advanced cholangiocarcinoma who developed escalating abdominal pain despite increasing doses of oxycodone, including patient-controlled analgesia.Alternative explanations were considered, including disease progression, visceral pain, and psychological distress.Following opioid rotation to morphine, there was rapid improvement in analgesia, followed by features of opioid-induced neurotoxicity at moderate doses.A potentially clinically significant interaction between carbamazepine and oxycodone was subsequently identified.This case highlights the importance of recognising enzyme-inducing medications as a potential cause of reduced opioid efficacy and demonstrates the clinical value of opioid rotation in complex cases.
Zitieren
APA
Dorward, K. M., & Nagar, S. D. (2026). Reduced Oxycodone Efficacy Associated With Carbamazepine Use in a Patient With Advanced Cholangiocarcinoma. Cureus. https://doi.org/10.7759/cureus.118925
Vancouver
Dorward KM, Nagar SD. Reduced Oxycodone Efficacy Associated With Carbamazepine Use in a Patient With Advanced Cholangiocarcinoma. Cureus. 2026. doi:10.7759/cureus.118925
BibTeX
@article{Dorward2026,
author = {Dorward, Kim M and Nagar, Sachin D},
title = {Reduced Oxycodone Efficacy Associated With Carbamazepine Use in a Patient With Advanced Cholangiocarcinoma},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.118925}
}
EUVIMED